Concentrum Wealth Management Myovant Sciences Ltd. Transaction History

Concentrum Wealth Management

  • $257 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
SELL
$14.31 - $23.87 $169,931 - $283,456
-11,875 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$18.94 - $26.99 $51,800 - $73,817
-2,735 Reduced 18.72%
11,875 $266,000
Q4 2020

Jan 20, 2021
BUY
$13.8 - $27.62 $29,325 - $58,692
2,125 Added 17.02%
14,610 $404,000
Q3 2020

Oct 23, 2020
BUY
$14.05 - $22.6 $175,414 - $282,161
12,485 New
12,485 $175,000

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Concentrum Wealth Management Portfolio

Follow Concentrum Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentrum Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Concentrum Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email